A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
Clinical trial NCT06452329 · COMPLETED
Trial details
- NCT number
- NCT06452329
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-28
- Primary completion
- 2025-07-29
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.